The latest news about Charles River Laboratories International, Inc. (CRL) includes a number of significant financial transactions and strategic endeavors. The Teacher Retirement System of Texas maintains holdings valued around $556,000 while Franklin Resources Inc. possesses a considerable stake valued at $180.38 million. Major purchases of CRL shares have been made by Norges Bank and Dimensional Fund Advisors LP.
On the corporate front, CRL has published its 2023 Corporate Citizenship Report and is reportedly showing strong growth in the Research Model Services (RMS) segment. It has also recently added Reshema Kemps-Polanco to the Board of Directors. In a bid to reduce reliance on animal testing, a comprehensive project on Alternative Methods Advancement has also been launched.
Financially, CRL's revenues have consistently beaten expectations, although a decrease in EVP Joseph Laplume's stake has occurred. A strategic partnership with Aitia targets neurodegenerative discovery programs and the launch of Viral Vector Reference Materials aims to streamline the transition to GMP. Its Q1 earnings and revenues have surpassed estimates, while gene therapy collaborations with both Axovia Therapeutics and Navega Therapeutics mark an emphasis on the biotech market.
Charles River Laboratories International CRL News Analytics from Wed, 08 Nov 2023 08:00:00 GMT to Sun, 26 May 2024 14:05:00 GMT - Rating 7 - Innovation 8 - Information 9 - Rumor -5
